Venus Expressing the Need for Antibiotic Research Models at Express Pharma

Saransh Chaudhary, Venus Remedies Limited & VMRC
Mr. Saransh Chaudhary, President, GCC, Venus Remedies Limited & CEO, VMRC

Saransh Chaudhary, President, Global Critical Care and CEO, VMRC, talked about the urgent need for new antibiotic research models at Express Pharma.

On various occasions in the past as well, Mr Chaudhary has spoken about the use of antibiotics, bacterial growth & resistance, and the impending threat of Antimicrobial Resistance (AMR). Here also explains such growing concerns and the need for dire steps to overcome them.

While the use of antibiotics is imperative in some medical cases, their unreasonable use can cause the microbes to become resistant to them, thus rendering these antibiotics ineffective. This behaviour has been observed for all major antibiotics, thus leading to the grave concern of Antimicrobial Resistance (AMR).

The problem has spread its roots globally, and the situation has already reached an alarming situation in India! However, one positive aspect is that the issue is now being recognized by different governments worldwide.

The team of Mr. Saransh Chaudhary at VMRC has been putting immense effort and in-depth research to combat the growing problem of AMR. To learn more about what he has to say, read out the entire published article.

Venus Remedies Limited

Venus Remedies Limited

Venus Remedies Ltd is a leading injectable manufacturer in the world. Having a presence in 75 countries, the company has nine globally benchmarked facilities apart from 11 overseas marketing offices.